187 related articles for article (PubMed ID: 26516155)
1. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.
Yan T; Lu L; Xie C; Chen J; Peng X; Zhu L; Wang Y; Li Q; Shi J; Zhou F; Hu M; Liu Z
Mol Cancer Ther; 2015 Dec; 14(12):2874-86. PubMed ID: 26516155
[TBL] [Abstract][Full Text] [Related]
2. Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method.
Yan T; Gao S; Peng X; Shi J; Xie C; Li Q; Lu L; Wang Y; Zhou F; Liu Z; Hu M
Pharm Res; 2015 Mar; 32(3):1141-57. PubMed ID: 25288013
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
4. Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.
Gao J; Zhou J; He XP; Zhang YF; Gao N; Tian X; Fang Y; Wen Q; Jia LJ; Jin H; Qiao HL
Oncotarget; 2016 May; 7(19):28612-23. PubMed ID: 27086920
[TBL] [Abstract][Full Text] [Related]
5. Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Zhou J; Wen Q; Li SF; Zhang YF; Gao N; Tian X; Fang Y; Gao J; Cui MZ; He XP; Jia LJ; Jin H; Qiao HL
Oncotarget; 2016 Aug; 7(31):50612-50623. PubMed ID: 27203676
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.
Rodríguez-Antona C; Donato MT; Boobis A; Edwards RJ; Watts PS; Castell JV; Gómez-Lechón MJ
Xenobiotica; 2002 Jun; 32(6):505-20. PubMed ID: 12160483
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450.
Nekvindova J; Mrkvicova A; Zubanova V; Hyrslova Vaculova A; Anzenbacher P; Soucek P; Radova L; Slaby O; Kiss I; Vondracek J; Spicakova A; Bohovicova L; Fabian P; Kala Z; Palicka V
Biochem Pharmacol; 2020 Jul; 177():113912. PubMed ID: 32173367
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.
Furukawa M; Nishimura M; Ogino D; Chiba R; Ikai I; Ueda N; Naito S; Kuribayashi S; Moustafa MA; Uchida T; Sawada H; Kamataki T; Funae Y; Fukumoto M
Cancer Sci; 2004 Jun; 95(6):520-9. PubMed ID: 15182434
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual Variation and Correlation of Cytochrome P450 Activities in Human Liver Microsomes.
Fang Y; Gao J; Wang T; Tian X; Gao N; Zhou J; Zhang HF; Wen Q; Jin H; Xing YR; Qiao HL
Mol Pharm; 2018 Nov; 15(11):5312-5318. PubMed ID: 30346185
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
Doehmer J; Weiss G; McGregor GP; Appel K
Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
[TBL] [Abstract][Full Text] [Related]
12. Quantification of human hepatocyte cytochrome P450 enzymes and transporters induced by HIV protease inhibitors using newly validated LC-MS/MS cocktail assays and RT-PCR.
Liu L; Mugundu GM; Kirby BJ; Samineni D; Desai PB; Unadkat JD
Biopharm Drug Dispos; 2012 May; 33(4):207-17. PubMed ID: 22498895
[TBL] [Abstract][Full Text] [Related]
13. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides.
Zhou XW; Ma Z; Geng T; Wang ZZ; Ding G; Yu-an B; Xiao W
J Ethnopharmacol; 2014 Dec; 158 Pt A():132-9. PubMed ID: 25456428
[TBL] [Abstract][Full Text] [Related]
15. 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human.
Marini S; Grasso E; Longo V; Puccini P; Riccardi B; Gervasi PG
Xenobiotica; 2003 Jan; 33(1):1-11. PubMed ID: 12519690
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient.
Ye L; Yang X; Guo E; Chen W; Lu L; Wang Y; Peng X; Yan T; Zhou F; Liu Z
PLoS One; 2014; 9(5):e96664. PubMed ID: 24797816
[TBL] [Abstract][Full Text] [Related]
17. Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes.
Fang Y; Gao N; Tian X; Zhou J; Zhang HF; Gao J; He XP; Wen Q; Jia LJ; Jin H; Qiao HL
Cell Physiol Biochem; 2018; 47(4):1604-1616. PubMed ID: 29949783
[TBL] [Abstract][Full Text] [Related]
18.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
19. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.
Marill J; Capron CC; Idres N; Chabot GG
Biochem Pharmacol; 2002 Mar; 63(5):933-43. PubMed ID: 11911845
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
